时尚健康 » 营养

抗癫药物有哪些 2013年国际抗癫痫联合会抗癫痫药使用指南

来源:[db:出处] 2020年05月08日 04:13   作者:fashion 抗癫药物有哪些 dropped failed

he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous analysis (Glauser et al., 2006) to provide a comprehensive update.

The prior analysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were analyzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.

This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat analysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs have been published. The combined analysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-analyses.

New efficacy/effectiveness findings include the following: levetiracetam and zonisamide have level A evidence in adults with partial onset seizures and both ethosuximide and valproic acid have level A evidence in children with childhood absence epilepsy.

There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for adults with partial onset seizures. Although ethosuximide and valproic acid now have level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.

These findings reinforce the need for multicenter, multinational efforts to design, conduct, and analyze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.

0
精彩推荐
“五界全品上架”鸿蒙智行家族震撼亮相2025成都车展
“五界全品上架”鸿蒙智行家族震撼亮相2025成都车展

8月30日,第28届成都国际汽车展览会隆重开幕,鸿蒙智行(HIMA, Harmony Intelligent MobilityAlliance)以五界全品上架为主题,首次携旗下AITO问界、LUXEED智界、STELATO享界...详细

问界新M5 Ultra跃影红亮相成都车展,现场上演“人从众”
问界新M5 Ultra跃影红亮相成都车展,现场上演“人从众”

在成都车展这场汽车行业的璀璨盛事中,各大品牌纷纷摩拳擦掌,展示自家的最新力作。而鸿蒙智行旗下问界新M5 Ultra以一抹耀眼的「跃影红」,成为展台中最瞩目的风景。车身色...详细

聚焦成都车展:尊界S800如何突破传统,定义新豪华
聚焦成都车展:尊界S800如何突破传统,定义新豪华

2025年的成都车展,车流如织,品牌争辉,而鸿蒙智行展台的尊界S800,却以一种沉静而极具张力的方式,吸引了无数目光的聚焦。它不靠夸张的设计语言博取眼球,也不依赖过往品...详细

从成都车展看尊界S800!销量口碑双丰收,高端市场搅局者
从成都车展看尊界S800!销量口碑双丰收,高端市场搅局者

在西部地区极具影响力的汽车盛会2025成都车展上,时代旗舰尊界S800于鸿蒙智行展台重磅登场,成功掀起了一场关于超豪华汽车的市场热潮与认知颠覆。​实力数据彰显尊界热度​...详细

本周热门
同仁堂健康双十一活动开启 “象食养医”倡导从健康的时候就关注健康

如果你想了解自己身体的秘密,让健康成为日常的生活方式,保持年轻的状态,实现抗衰老,逆生长的美好愿望,那么今年双十一的这场活动你一定不要错过。11月1日,同仁堂健康...详细